In transfusion-dependent, angiodysplasia-related anemia, adding octreotide to usual care reduced transfusions at 1 y

Duncan J Flynn; Joseph D Feuerstein

doi:10.7326/ANNALS-24-00517-JC

In transfusion-dependent, angiodysplasia-related anemia, adding octreotide to usual care reduced transfusions at 1 y

Ann Intern Med. 2024 Jun;177(6):JC69. doi: 10.7326/ANNALS-24-00517-JC. Epub 2024 Jun 4.

Authors

Duncan J Flynn¹, Joseph D Feuerstein¹

Affiliation

¹ Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA (D.J.F., J.D.F.).

PMID: 38830221
DOI: 10.7326/ANNALS-24-00517-JC

Abstract

Goltstein LC, Grooteman KV, Bernts LH, et al. Standard of care versus octreotide in angiodysplasia-related bleeding (the OCEAN study): a multicenter randomized controlled trial. Gastroenterology. 2024;166:690-703. 38158089.

MeSH terms

Aged
Anemia* / drug therapy
Anemia* / etiology
Anemia* / therapy
Angiodysplasia* / complications
Blood Transfusion
Female
Gastrointestinal Agents / therapeutic use
Gastrointestinal Hemorrhage / etiology
Gastrointestinal Hemorrhage / therapy
Humans
Male
Middle Aged
Multicenter Studies as Topic
Octreotide* / therapeutic use
Randomized Controlled Trials as Topic

Substances

Gastrointestinal Agents
Octreotide